ZANNETTI, ANTONELLA
 Distribuzione geografica
Continente #
AS - Asia 1.894
NA - Nord America 1.169
EU - Europa 562
SA - Sud America 377
AF - Africa 30
OC - Oceania 2
Totale 4.034
Nazione #
US - Stati Uniti d'America 1.109
SG - Singapore 796
CN - Cina 402
BR - Brasile 301
IT - Italia 211
VN - Vietnam 204
HK - Hong Kong 186
FR - Francia 109
BD - Bangladesh 79
NL - Olanda 74
KR - Corea 68
FI - Finlandia 45
JP - Giappone 43
IN - India 34
DE - Germania 28
GB - Regno Unito 28
AR - Argentina 26
CA - Canada 22
MX - Messico 16
PL - Polonia 14
IL - Israele 12
CL - Cile 11
CO - Colombia 11
EC - Ecuador 11
UA - Ucraina 10
ZA - Sudafrica 9
ID - Indonesia 8
IQ - Iraq 8
PK - Pakistan 8
UZ - Uzbekistan 8
ES - Italia 7
SA - Arabia Saudita 7
PY - Paraguay 6
RU - Federazione Russa 6
TR - Turchia 6
LT - Lituania 5
VE - Venezuela 5
EG - Egitto 4
LV - Lettonia 4
MA - Marocco 4
AT - Austria 3
AZ - Azerbaigian 3
CR - Costa Rica 3
DZ - Algeria 3
IE - Irlanda 3
JM - Giamaica 3
KE - Kenya 3
PE - Perù 3
PH - Filippine 3
SV - El Salvador 3
UY - Uruguay 3
AU - Australia 2
BB - Barbados 2
BE - Belgio 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
SE - Svezia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
MG - Madagascar 1
MO - Macao, regione amministrativa speciale della Cina 1
MR - Mauritania 1
MY - Malesia 1
NI - Nicaragua 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
Totale 4.034
Città #
Singapore 492
Santa Clara 373
Hong Kong 185
Hefei 146
San Jose 142
Ashburn 101
Beijing 92
Lauterbourg 89
Ho Chi Minh City 72
Seoul 67
Los Angeles 64
Dallas 48
Naples 42
Hanoi 40
Tokyo 33
Afragola 23
New York 23
São Paulo 20
Lappeenranta 17
Rome 15
Buffalo 14
Council Bluffs 14
Helsinki 14
Marigliano 14
Milan 13
Turku 13
Rio de Janeiro 12
Belo Horizonte 11
Casandrino 10
Warsaw 10
Brooklyn 9
Frankfurt am Main 9
Giugliano in Campania 9
Chicago 8
Da Nang 8
Falkenstein 8
Minamishinagawa 8
Montreal 8
Tashkent 8
Bengaluru 7
Munich 7
Orem 7
Soccavo 7
Fortaleza 5
Manchester 5
Ninh Bình 5
Riga 5
Shanghai 5
Sorocaba 5
Thái Bình 5
Bari 4
Biên Hòa 4
Brasília 4
Can Tho 4
Curitiba 4
Denver 4
Dhaka 4
Ercolano 4
Guangzhou 4
Guayaquil 4
Haiphong 4
London 4
Mexico City 4
Paris 4
Phoenix 4
Quito 4
Santiago 4
Springfield 4
Amsterdam 3
Ankara 3
Baghdad 3
Baku 3
Bauru 3
Boston 3
Campos dos Goytacazes 3
Cape Town 3
Casablanca 3
Chennai 3
Dongguan 3
Dublin 3
Duque de Caxias 3
Elk Grove Village 3
Hamilton 3
Houston 3
Hyderabad 3
Jeddah 3
Johannesburg 3
Kingston 3
Kyiv 3
Lahore 3
Lima 3
Limeira 3
Marília 3
Miami 3
Mumbai 3
Nanjing 3
Nha Trang 3
Niterói 3
Orlando 3
Piscataway 3
Totale 2.515
Nome #
Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion 122
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies 116
Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells 90
PET imaging of brain TSPO expression in a mouse model of Experimental Autoimmune Encephalomyelitis using [18F]DPA-714 87
In vivo imaging of CNS microglial activation/macrophage infiltration with combined [F-18]DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis 82
Therapeutic Potential of a Novel alpha(v)beta(3) Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type 81
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors 78
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer 75
Optimization of Short RNA Aptamers for TNBC Cell Targeting 75
The phosphatase Shp1 interacts with and dephosphorylates cortactin to inhibit invadopodia function 70
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells 69
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFR? Aptamer. Theranostics. 67
A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell Plasticity 66
Gefitinib, a selective, tyrosine kinase inhibitor increases 99mTc-MIBI uptake in Bcl-2 overexpressing breast cancer cells. 65
IN VITRO AND IN VIVO EVALUATION OF 111In-DTPAGlu-G-CCK8 FOR CHOLECYSTOKININ-B RECEPTOR IMAGING. 65
Preclinical Imaging Evaluation of miRNAs' Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review 61
Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells 59
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer 56
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis 56
Lipid- and polymer-based formulations containing TNF-α inhibitors for the treatment of inflammatory bowel diseases 56
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 55
Bone Marrow uptake of 99mTc-MIBI in patients with multiple myeloma 55
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells 55
New and selective radiolabeled alpha(v)beta(3) antagonist as tracer in tumor diagnosis 54
Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches 2.0 54
In vivo imaging and characterization of [18F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET 54
Editorial: Tumor Microenvironment: Molecular Mechanisms and Signaling Pathways Involved in Metastatic Progression 52
Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer 50
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFR? Aptamer 49
Aptamer-mediated impairment of EGFR-integrin alpha v beta 3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers 49
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 49
Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer 48
A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion 47
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRbeta aptamer 47
Autocrine signals increase ovine mesenchymal stem cells migration through Aquaporin-1 and CXCR4 overexpression 46
18F-FLT PET/CT to guide therapy with EGFR antagonists and Bcl-xL inhibitors in non-small cell lung cancer. 45
TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities 45
3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer 43
Dynamic coupling of 99mtc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients 42
Chemical Modification for Proteolytic Stabilization of the Selective alpha(v)beta(3) Integrin RGDechi Peptide: in Vitro and in Vivo Activities on Malignant Melanoma Cells 41
PET/CT in cancer research: from preclinical to clinical applications 40
IN VIVO IMAGING OF ALPHA(V)BETA(3) INTEGRIN EXPRESSION WITH A RADIOLABELED CHIMERIC RDG PEPTIDE 40
In Vitro and In Vivo Evaluation of 111In- DTPAGlu-G-CCK8 for Cholecystokinin-B Receptor Imaging 40
Effects of Thyroid Blockade on Brain Imaging of Dopamine Transporter in Normal Mice 40
Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells 40
99mTc-MIBI in the evaluation of breast cancer biology 40
Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation. 40
Role of Aquaporins in the Physiological Functions of Mesenchymal Stem Cells 38
Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors 38
inhibition of bone marrow-derived mesenchymal stem cells homing towards triple-negative breast cancer microenvironment using an anti-PDGFRbeta aptamer 38
Functional imaging of multidrug resistance in breast cancer 37
MIBI as prognostic factor in breast cancer. 35
Radiolabeling approaches for cholecystokinin B receptor imaging 35
Molecular imaging of drug resistance in cancer 34
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma 33
99mTc-MIBI in the evaluation of breast cancer biology 33
Inhibition of Sp1 activity by a decoy PNA-DNA chimera prevents urokinase receptor expression and migration of breast cancer cells 33
A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growth 32
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma 32
Novel and selective αvβ3 receptor peptide antagonist: Design, synthesis, and biological behavior 32
High-Frequency Ultrasound-Guided Injection for the Generation of a Novel Orthotopic Mouse Model of Human Thyroid Carcinoma 32
A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors 32
18F-FLT PET/CT to guide therapy with EGFR antagonists and Bcl-xL inhibitors in non-small cell lung cancer 30
Nuclear imaging in cancer theranostics 30
In vivo imaging of alpha(v)beta(3) integrin expression with a radiolabeled chimeric RGD peptide 30
Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype 29
Stato dell'arte dell'imaging preclinico in oncologia 29
MicroPET/CT of mice bearing alpha(v)beta(3)-expressing tumors by a 18F-labeled bifunctional chimeric RGD peptide 28
A RADIOLABELING SYNTHESIS OF RGD ECHI WITH 18FLUORIDE- 28
Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors 28
A New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 28
A NEW AND SELECTIVE RADIOLABELED ALPHAVBETA3 PEPTIDE ANTAGONIST AS TRACER IN TUMOR DIAGNOSIS. 28
Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer 28
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 28
Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior. 28
Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma. 27
Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-X-L modulation of inositol trisphosphate receptor type 3 27
Combined Imaging with 18F-FLT PET/CT and 99m-Tc-Hynic-Annexin V SPECT for Personalized Therapy with EGFR Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer 27
IMAGING IN VIVO DELL'ESPESSIONE DELL'INTEGRINA alfa(v)beta(3) CON UN PEPTIDE CHIMERICO RGD RADIOMARCATO 27
AN IMPROVED RADIOLABELING SYNTHESIS OF RGDECHI WITH 18F-FLUORIDE. 27
Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models 27
Inhibition of early (99m)Tc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma 26
Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines 26
In Vitro and In Vivo Evaluation of 111In- DTPAGlu-G-CCK8 for Cholecystokinin-B Receptor Imaging 25
Novel and selective alpha v beta 3 receptor peptide antagonist: Design, synthesis and biological behaviour 25
PET/CT in cancer research: from preclinical to clinical applications 23
Coordinate upregulation of Sp1 DNA binding activity and urokinase receptor expression in breast carcinoma 23
New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 23
High Frequency Ultrasound for the development of an Orthotopic mouse model of Human Follicular Thyroid Carcinoma 23
Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer 22
A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro: perspectives for blocking tumor-stroma communication and signaling 22
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRB aptamer 21
Molecular imaging of tumor microenvironment: challenges and perspectives 21
Elevated Expression of the Tyrosine Phosphatase SHP-1 Defines a Subset of High-Grade Breast Tumors 19
Urokinase Receptor Interacts with avb5 Vitronectin Receptor, Promoting Urokinase-dependent Cell Migration in Breast Cancer 18
A NEW AND SELECTIVE RADIOLABELLED v 3 PEPTIDE ANTAGONIST AS TRACER IN TUMOR DIAGNOSIS 16
Longitudinal evaluation with High Frequency Ultrasound imaging of response to CXCR4 new cyclic peptide antagonist with conventional chemotherapy in colorectal cancer mice model 16
Totale 4.153
Categoria #
all - tutte 13.805
article - articoli 12.058
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 243
Totale 26.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202443 0 0 0 0 0 0 0 0 1 5 22 15
2024/20251.626 26 13 165 57 368 77 40 70 85 93 338 294
2025/20262.386 106 280 188 320 414 102 368 97 147 144 137 83
2026/202798 98 0 0 0 0 0 0 0 0 0 0 0
Totale 4.153